ADJUnct Semaglutide Treatment in Type 1 Diabetes

NCT05537233 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

115

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes
Obesity

Interventions

DRUG: Semaglutide
DRUG: Placebo

Sponsor

Viral N. Shah

Collaborators

[object Object]